Ethical Aspects and Dilemmas of Preparing, Writing and Publishing of the Scientific Papers in the Biomedical Journals

Abstract

Introduction:In this paper author discussed about preparing and submitting manuscripts - scientific, research, professional papers, reviews and case reports. Author described it from the Editor’s perspective, and specially talked about ethical aspects of authorship, conflict of interest, copyright, plagiarism and duplicate publication from the point of view of his experiences as Editor-in-Chief of several biomedical journals and Chief of Task Force of European Federation of Medical Informatics journals and member of Task Force of European Cardiology Society journals. The scientific process relies on trust and credibility. The scientific community demands high ethical standards to conduct biomedical research and to publish scientific contents. During the last decade, disclosure of conflicts of interest (COI ), (also called competing loyalties, competing interests or dual commitments), has been considered as a key element to guarantee the credibility of the scientific process. Biases in design, analysis and interpretation of studies may arise when authors or sponsors have vested interests. Therefore, COI should be made clear to the readers to facilitate their own judgment and interpretation of their relevance and potential implications.Results and Discussion:Authors are responsible to fully disclose potential COI . In October 2009 the ICMJE proposed an electronic “uniform” format for COI disclosure. Four main areas were addressed: authors´ associations with entities that supported the submitted manuscript (indefinite time frame), associations with commercial entities with potential interest in the general area of the manuscript (time frame 36 months), financial association of their spouse and children and, finally, non-financial associations potentially relevant to the submitted manuscript. Consumers of medical scholarship expect a reliable system of disclosure in which journals and authors make disclosures appropriately and consistently. There is a stigma surrounding the reporting of COI that should be progressively overcome. Further actions are required to increase awareness of the importance of COI disclosure and to promote policies aimed to enhance transparency in biomedical research. In this article author discuss about important ethical dilemmas in preparing, writing and publishing of scientific manuscripts in biomedical journals.

Reporting a Population Pharmacokinetic–Pharmacodynamic Study: A Journal’s Perspective

“…For information on basic critical appraisal concepts, see references [12,13]. Lastly, the current article can be read in conjunction with several other articles that offer guidance for scientific writing (see references [14][15][16][17][18][19] for some recent examples), as well as articles that propose guidelines for the reporting of different types of trials [20][21][22][23][24]. …”

Review of Most Important Biomedical Databases for Searching of Biomedical Scientific Literature

“…Each scientific paper is recorded in data written by rules recommended by several scientific associations and committees. [1][2][3][4][5][6][7][8][9][10][11][12][13] Databases can contain information about the author (including bibliographic data and abstract) and the original work. Data set determines the type of base as: (a) bibliographic databases, (b) citation databases, (c) full-text databases.…”

Knowledge Production in Two Types of Medical PhD Routes—What’s to Gain?

“…The publishing time (from completion to publication) of a scientific research in biomedical scientific journals was estimated to vary from 6 to12 months in general [48] or between 31 and 533 days [49], but may be longer for some fields. As the prospective publication-based theses group revealed significantly lower time span than the traditional theses group (p < 0.05, Table 3), PhD students could benefit from a shorter publication time in order to confront the growing pressure to publish during candidature.…”